Smith & Nephew beginning shipments of Mosaic Plasty instruments for knee cartilage repair in July.
This article was originally published in The Gray Sheet
SMITH & NEPHEW MOSAIC PLASTY INSTRUMENT SYSTEM FOR KNEE CARTILAGE REPAIR will begin shipping July 1 in the U.S. following completion of product-specific training for Smith & Nephew Endoscopy's 200-rep sales force, the company says. An international launch is slated for August 1 through distributors. The "specially designed" instruments are designed to perform "autogenous osteochondral grafting," an articular cartilage knee repair technique for treating lesions resulting from sports injuries.
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.